This HTML5 document contains 150 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1038/
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51583386
rdf:type
wikibase:Item
schema:description
vitskapeleg artikkel artículo científico publicado en 2006 wissenschaftlicher Artikel 2006年の論文 научная статья artikulong pang-agham 2006年学术文章 مقالة علمية نشرت في 19 أكتوبر 2006 ১৯ অক্টোবর ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ naučni članak 2006年學術文章 2006年學術文章 2006年學術文章 2006年学术文章 artigo científico artículu científicu vitenskapelig artikkel мақолаи илмӣ наукова стаття, опублікована в жовтні 2006 article scientifique bilimsel makale 2006 nî lūn-bûn 2006年學術文章 artykuł naukowy научна статия บทความทางวิทยาศาสตร์ scientific article published on 19 October 2006 artikull shkencor научни чланак სამეცნიერო სტატია 2006年學術文章 wetenschappelijk artikel επιστημονικό άρθρο vetenskaplig artikel 2006年学术文章 artigo científico videnskabelig artikel articol științific vědecký článek artigo científico bài báo khoa học teaduslik artikkel article scientific 2006년 논문 מאמר מדעי scientific article published on 19 October 2006 scientific article published on 19 October 2006 2006年学术文章 artikel ilmiah 2006年学术文章 vedecký článok tieteellinen artikkeli научни чланак scienca artikolo 2006年学术文章 articolo scientifico tudományos cikk article científic
p:P577
wds:Q51583386-F1933E89-2BB9-4E54-8457-13EE84603007
wdt:P577
2006-10-19T00:00:00Z
p:P2888
wds:Q51583386-7DE764BB-1013-46FD-B537-D6FE5814146F
wdt:P2888
n10:sj.leu.2404416
p:P2860
wds:Q51583386-45FEC6F9-7E7A-445C-AD81-6DE38893DEF2 wds:Q51583386-46C23389-B09C-46A4-AF1D-63EFCBE2894C wds:Q51583386-47797EEF-A948-4773-A158-F90513AEB822 wds:Q51583386-4960CDD7-B106-467B-B7A4-5010B3DF641C wds:Q51583386-5BCC29F5-A8CC-4159-BCB8-B16EDE85B0BE wds:Q51583386-62A20D21-F1A5-4C0A-A892-BFE95F7BABFA wds:Q51583386-22FAB359-85C8-4392-B0D0-F06E478660ED wds:Q51583386-2887DFE8-38E7-4E76-9070-B50ED3B21C6D wds:Q51583386-AEF9BB21-EB1A-475A-AF0B-431453DB3B8E wds:Q51583386-B4B0FCB5-F28B-4121-A1F2-2750A64077A4 wds:Q51583386-BFA18E48-0C7C-4852-BEBC-A34CED12DB28 wds:Q51583386-72140C1A-875E-45F0-A69B-9C9D2BB27CC2 wds:Q51583386-72414D28-6544-4B44-B366-A4B76428C2F0 wds:Q51583386-72F800C8-386B-428A-BDF2-85245FD1B5AF wds:Q51583386-7C3CA96D-F825-43F5-A0FD-B63A00905D3D wds:Q51583386-8D824AA9-ADEB-4718-B1E1-90CC762F632C wds:Q51583386-99A23A23-AF59-46ED-A7F0-19F4DA542A2C wds:Q51583386-FF47AADF-B70E-4212-A476-FCD986359AC4 wds:Q51583386-C24B69A9-5D29-4509-A49F-08708B1D47BF wds:Q51583386-E1E62A2D-8A62-4A6A-8BE5-ABA2A41CB6D8 wds:Q51583386-EC628B92-2927-4D99-944E-2521A2A4E059 wds:Q51583386-F161FE6E-4D70-45DF-8D88-A6605501303A
wdt:P2860
wd:Q40633064 wd:Q61868167 wd:Q47663990 wd:Q46378902 wd:Q34155712 wd:Q43430617 wd:Q45191343 wd:Q34128389 wd:Q47435734 wd:Q45287934 wd:Q34402999 wd:Q57369872 wd:Q28146150 wd:Q74531389 wd:Q40701090 wd:Q54017366 wd:Q54703436 wd:Q33344749 wd:Q73210717 wd:Q40542317 wd:Q44242585 wd:Q47720622
p:P2093
wds:Q51583386-BC566C55-2B1F-4DE8-96F7-8B3A6C892882 wds:Q51583386-B3DE2FE2-4A83-4463-8524-5FAB231471A4 wds:Q51583386-AFEEA97C-1DBC-4F67-84C4-121CD9CC32E6
wdt:P2093
Hillmen P Jack AS de Tute R
rdfs:label
Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens. Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens. Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens.
skos:prefLabel
Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens. Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens. Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens.
schema:name
Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens. Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens. Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens.
p:P50
wds:Q51583386-AF17703B-7AB6-4F83-9F86-07A298946403
wdt:P50
wd:Q38544276
p:P1476
wds:Q51583386-55892F3E-6F9D-49B3-9660-5845A4070321
wdt:P1476
Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens.
p:P304
wds:Q51583386-E2D5D405-97B4-4E13-85DD-F514403A957D
wdt:P304
2102-2110
p:P31
wds:Q51583386-955B0B54-A3DA-47A5-8E3D-0705216FA5CA
wdt:P31
wd:Q13442814
p:P921
wds:Q51583386-CB699E9F-77C7-46AF-9275-EF88B2AC9C0D wds:Q51583386-2D55CAD7-E24F-4E2E-86D9-916BED296BF4 wds:Q51583386-3E954CB2-B104-4180-B39D-4963AAF950C5
wdt:P921
wd:Q1141429 wd:Q715347 wd:Q29496
p:P698
wds:Q51583386-20254CA0-3927-4CA8-879E-B4554DA4F783
wdtn:P698
n13:17051247
wdt:P698
17051247
p:P1433
wds:Q51583386-D50B1D69-1E93-404C-BF42-3B664282B7E2
wdt:P1433
wd:Q6534498
p:P433
wds:Q51583386-A52B0C7F-689E-4D40-8E72-8F4D0716C4E4
p:P478
wds:Q51583386-38977CB6-2B72-41F4-8793-7732CE777770
wdt:P433
12
wdt:P478
20
p:P356
wds:Q51583386-6FD8C1DA-3A52-464A-AD66-5B72B596B10B
wdtn:P356
n8:SJ.LEU.2404416
wdt:P356
10.1038/SJ.LEU.2404416
p:P5875
wds:Q51583386-C9159E0E-B5BA-401B-B806-01B77C39CE3F
wdt:P5875
6745064